Accelerating the Development of a Pathbreaking Universal Drug Regimen for TB

“Hi! My name is mycobacterium tuberculosis (MT for short). I traveled here from Washington, D.C. to attend the World Health Assembly. I’m a global killer that knows no boundaries. However, with better drugs, the Center for Global Development (CGD) wants to make me a rare collectible.”

Last year’s high-level political declaration on the fight against tuberculosis committed to mobilizing sufficient and sustainable financing for universal access to quality prevention, diagnosis, treatment and care of tuberculosis (TB). To achieve this, we need new ideas and innovation to end TB.

In March, researchers at the Center for Global Development and Office of Health Economics posted a consultation draft of a policy proposal for a Market-Driven, Value-Based Advanced Commitment (MVAC). The MVAC is a new mechanism that puts middle-income country governments in the driver’s seat to accelerate R&D for diseases that affect the world’s poor—specifically, the 10 million men, women, and children who develop tuberculosis (TB) disease each year and desperately need better therapies. The model would help redirect private-sector R&D investments where they’re needed most while ensuring affordable access and at-scale deployment when innovative drugs come to market. In the long run, the MVAC is intended to serve as a bridge between the dysfunctional status quo and a more sustainable and effective R&D ecosystem—one which more closely emulates the positive characteristics of high-income country markets for healthcare products.

The MVAC consultation process remains ongoing; all input we receive will inform our revision of the consultation draft. Read more about the consultation process. We look forward to continuing this dialogue throughout the week. Please look for MT the microbe around the Assembly– we will have a few for delegates to take home– or email me (rsilverman@cgdev.org) to arrange a time to meet. You can also engage with our team on Twitter using #InnovateToEndTB.

By harnessing the power of innovation and partnerships, we will put an end to TB once and for all.

This post was written by Rachel Silverman, Policy Fellow at the Center for Global Development, a Global Health Council member. The Center for Global Development works to reduce global poverty and improve lives through innovative economic research that drives better policy and practice by the world’s top decision makers.

 

 

 

 

2 Comments

  1. John Sayo paitah on May 20, 2019 at 6:15 pm

    I am a TB survivor and also a champion from maa community health workers cbo in kajiado county Kenya I am a TB Ambassador in my community and my country I am expecting to be a role model in world and advocates my experience to affected communities.

  2. John Sayo paitah on May 20, 2019 at 6:20 pm

    I support this this activity and like to be one of those to advocate.

Leave a Comment